FLUBLOK QUADRIVALENT Rx
Generic Name and Formulations:
Quadrivalent, recombinant hemagglutinin (virus types A and B); contains a total of 180mcg recombinant hemagglutinin per 0.5mL dose; formulation changes annually; soln for IM inj; egg-, antibiotic-, preservative-free.
Sanofi Pasteur, Inc.
Indications for FLUBLOK QUADRIVALENT:
≥18yrs: 0.5mL by IM inj once in the deltoid.
3–<18yrs: not established.
Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Immunosuppressed. Have appropriate treatment available to manage anaphylaxis. Pregnancy. Nursing mothers.
Concomitant vaccines: insufficient data (see full labeling). Immunosuppressants: may get suboptimal response.
Inj site tenderness and pain, headache, fatigue, myalgia, arthralgia.
Single-dose prefilled syringes (0.5mL)—10
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Venlafaxine XR Safe, Effective in Treating Generalized Anxiety Disorder
- Duration of Untreated Depression Predicts Depression Severity
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- Elevated Dopamine Synthesis Capacity Observed in Both Bipolar and Schizophrenia
- SSRI Use Associated With Increased Type 2 Diabetes Risk in Young Adults
- Specialty Physicians Experiencing Lack of Income Growth
- Improved Patient-Provider Communication Needed Following Urgent Care Visits
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV